Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
Developing a comprehensive site selection process for a cancer network in a resource-limited settings in sub-Saharan Africa
05/2017
Wirth, Megan, Blumberg, Dikla, Mosby-Griffin, Kimberly, Vena, Don
Challenges in implementing and managing clinical trials in developing countries: lessons learned by the national cancer institute's (NCI) AIDS malignancy consortium (AMC)
05/2017
Wirth, Megan, Blumberg, Dikla, Mosby-Griffin, Kimberly, Vena, Don
Best practices for study drug management and accountability throughout the study lifecycle in multi-site randomized controlled trials
05/2017
Blumberg, Dikla, Novo, Patricia , Jeffries, Beth, Yesko, Lauren, Matthews, Abigail G, Collins, Julia, Salazar, Dagmar, Jelstrom, Eve, Wright, Matthew, Kondapaka, Radhika
Tailoring a comprehensive website to support a clinical research network
05/2017
Yesko, Lauren, Blumberg, Dikla , Vanveldhuisen, Paul, McCormack, Jennifer, Frasketi, Michael, McNeil, Jordan, Sabina, Heather
Informed consent process enhancement approaches for research participants who may be considered vulnerable populations
05/2017
Wright, Matthew, Lynne, Julia, Hardter, Eric, Kondapaka, Radhika, Williams, Kayla, Salazar, Dagmar, Shmueli-Blumberg, Dikla, Jelstrom, Eve, Lindblad, Robert
The training documentation form-Going beyond the basics for the national institute on drug abuse (NIDA) national drug abuse treatment clinical trials network (CTN)
05/2017
Williams, Tracee, Kondapaka, Radhika, Shmueli-Blumberg, Dikla, Wright, Matthew, Salazar, Dagmar, Williams, Kayla, Collins, Julia, Jelstrom, Eve, Lindblad, Robert
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial
04/2024
Shulman, M., Provost, S., Ohrtman, K., Novo, P., Meyers-Ohki, S., Van Veldhuisen, P., Oden, N., Otterstatter, M., Bailey, G. L., Liu, D., Rotrosen, J., Nunes, E. V., Weiss, R. D.
Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion
12/2023
Ip, M. S., Scott, I. U. , VanVeldhuisen, P. C., Oden, N. L., Blodi, B. A., Score Investigator Group